1. Interactions between 14-3-3 Proteins and Actin Cytoskeleton and Its Regulation by microRNAs and Long Non-Coding RNAs in Cancer
   Jaya Aseervatham, 2022, Endocrines CrossRef
2. Expression of 14‐3‐3 sigma and eta proteins is unrelated to survival in metastatic high‐grade serous carcinoma
   Ben Davidson et al, 2018, APMIS CrossRef
3. 14-3-3 Sigma is a Useful Immunohistochemical Marker for Diagnosing Ovarian Granulosa Cell Tumors and Steroid Cell Tumors
   Longwen Chen et al, 2013, International Journal of Gynecological Pathology CrossRef
4. Molecular carcinogenesis in equine penile cancer: A potential animal model for human penile cancer
   Alejandro Suárez-Bonnet et al, 2018, Urologic Oncology: Seminars and Original Investigations CrossRef
5. IPA Analysis of Cervicovaginal Fluid from Precancerous Women Points to the Presence of Biomarkers for the Precancerous State of Cervical Carcinoma
   Xaveer Van Ostade et al, 2014, Proteomes CrossRef
6. 14-3-3σ expression is associated with poor pathological complete response to neoadjuvant chemotherapy in human breast cancers
   Yukiko Nakamura et al, 2012, Breast Cancer Research and Treatment CrossRef
7. Comparison of immunoreaction between two commercial antibodies against 14-3-3σprotein in canine tissues
   Alejandro Suárez-Bonnet et al, 2016, Journal of Applied Animal Research CrossRef
8. iTRAQ-based quantitative proteomic analysis of differentially expressed proteins in chemoresistant nasopharyngeal carcinoma
   Kun Wang et al, 2018, Cancer Biology & Therapy CrossRef
9. High expression of 14‑3‑3ơ indicates poor prognosis and progression of lung adenocarcinoma
   Junfei Feng et al, 2022, Oncology Letters CrossRef